Could a single weekly shot replace daily insulin injections?
NCT ID NCT06767748
Summary
This study is testing if a new, once-weekly insulin injection called GZR4 is as effective and safe as a standard daily insulin for adults with type 2 diabetes. It will involve about 620 people who are already using a long-acting insulin. The main goal is to see which treatment better controls long-term blood sugar levels, while also tracking side effects like low blood sugar and weight changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gan & Lee Pharmaceuticals Shandong Co., Ltd.
Linyi, Shandong, 276000, China
Conditions
Explore the condition pages connected to this study.